HBL Hadasit Bio Holdings Investor
HBL Hadasit Bio Holdings is the medical research center of the Hadassah University Hospital.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2005-01-01
Funding Status:
IPO
Investor Type:
Micro VC, Venture Capital
Investment Stage:
Early Stage Venture
Number Of Exits:
1
Total Funding:
2000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2015-06-28
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership